Released N-Glycan Analysis of Infliximab-dyyb including Sialylated Glycans using a bioZen 2.6 μm Glycan Column

Abstract:

Glycosylation of biologics during recombinant synthesis must be fully characterized for therapeutic development. Employing a bioZen Glycan LC column for a HILIC-mode separation of released N-glycans is an effective protocol.

Document Type:

Technical Notes

Industries:

Pharmaceutical/Biopharmaceutical Life Science

Techniques:

HPLC / UHPLC Sample Prep

Brands:

bioZen

PDF Link:

Click here